Imexpharm

Imexpharm EBIT per Employee

The EBIT per Employee of Imexpharm (IMP.VN) as of Oct 26, 2026 is 341.03 M VND. In the previous year, EBIT per Employee was 306.24 M VND — a change of 11.36% (higher).

EBIT per Employee

341.03 MVND

YoY

11.36%

Last updated:

EBIT per Employee of Imexpharm is 2025 341.03 M VND. EBIT per Employee of Imexpharm was 2024 306.24 M VND. It decreases by 11.36% higher compared to the previous year.

The Imexpharm EBIT per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Employee
Date
EBIT per Employee
Jan 1, 2018
116.80 M VND
Jan 1, 2019
149.74 M VND
Jan 1, 2020
193.62 M VND
Jan 1, 2021
182.47 M VND
Jan 1, 2022
218.66 M VND
Jan 1, 2023
281.00 M VND
Jan 1, 2024
306.24 M VND
Jan 1, 2025
341.03 M VND
The Imexpharm EBIT per Employee history
YEAREBIT per EmployeeYoY
341.03 MVND+11.36%
306.24 MVND+8.98%
281.00 MVND+28.51%
218.66 MVND+19.83%
182.47 MVND-5.76%
193.62 MVND+29.31%
149.74 MVND+28.19%
116.80 MVND+22.69%
95.20 MVND+8.16%
88.03 MVND+12.25%
78.42 MVND+4.57%
74.99 MVND—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Imexpharm Stock analysis

What does Imexpharm do? Imexpharm Corp manufactures and trades pharmaceuticals, medicinal chemicals, and botanical products, including antiseptics, traditional medicine, medical equipment, cosmetics, and supplemental food and drinks. The company provides packaging and warehousing services specifically for pharmaceutical storage. It also cultivates medicinal herbs. Imexpharm Corp serves the pharmaceutical industry and healthcare sector through its manufacturing, import, export, and trade operations, targeting businesses requiring medicinal products and services. The company's revenue streams include the sale of manufactured pharmaceuticals, imported and exported goods, and services such as packaging and warehousing. Its customers are businesses in the healthcare sector, including distributors and retailers of pharmaceuticals, medical equipment, and related products. The firm's operations span manufacturing, import, export, and trade, with additional services supporting the pharmaceutical supply chain. Imexpharm Corp's product portfolio covers a wide range of medicinal and health-related items, from antiseptics to supplemental food and drinks. The company's involvement in medicinal herb cultivation supports its production of traditional medicine and herbal-based products. This vertical integration enhances its ability to supply comprehensive solutions to healthcare businesses. Imexpharm is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Imexpharm stock

EBIT per Employee of Imexpharm is 341.03 M VND in 2025.

EBIT per Employee of Imexpharm changed from 306.24 M VND to 341.03 M VND, representing a 11.36% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Employee Imexpharm since 2006 – with annual values, charts, and detailed analysis.

EBIT per employee measures operating profit per employee, showing how efficiently the workforce generates operating earnings.

EBIT per Employee's VND is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT per Employee's Imexpharm historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Imexpharm

All Key Metrics — Imexpharm